Theiss Bendixen

Theiss Bendixen

@theissbendixen.bsky.social

Data science & Bayes at Novo Nordisk | Author of "The Data Analyst's Guide to Cause and Effect" (https://theissbendixen.com/dag-book/) | Writing a book on Bayes in drug development | Board member, https://giveffektivt.dk/ www.theissbendixen.com

142 followers72 following90 posts

"Descriptive statistics also require causal inference" So true! In the Data Analyst's Guide, we illustrate it with a fun example: a registry study on spirituality among Danes 👇 theissbendixen.com/dag-book/

Richard McElreath 🐈‍⬛@rmcelreath.bsky.social

Modeling non-response is an example I like to use when arguing that "descriptive" statistics also require causal inference. To describe the population, you have to model what causes the sample. Similar to occupancy modeling in ecology in many ways.

Theiss Bendixen reposted

View full thread
View full thread

Cephalopods are also mostly short-lived, asocial and cannibalistic, they exhibit little to no parental care or pair-bonding, and usually die shortly after first reproduction. This runs counter to theories of brain size and intelligence in large-brained vertebrates.

In short, cephalopods are an evolutionary enigma and a promising animal group on which to evaluate prominent hypotheses on the evolutionary drivers of brain size. So that's what we set out to do!

View full thread

Cephalopods are phylogenetically very distant from animals usually considered “brainy,” branching off from the vertebrates over 500 million years ago. And yet, many cephalopods possess large and complex nervous systems and exhibit flexible behaviours.

First of all, this was a *huge*, multi-year (+7 years) team effort! My own research has taken a few turns since we began this, but our review, database and analyses are still a massive contribution to the field of cephalopod and comparative brain studies, in my humble opinion.

Brilliant read! I'd add that several of the big COVID trials took an explicit Bayesian approach, which facilitates interim looks at the data and allows a trial to stop if the treatment is clearly working (or not). @statberry.bsky.social gives a readable overview here: www.mdpi.com/2077-0383/14...

mdpi.commdpi.com
Saloni@scientificdiscovery.dev

New post! Most people didn’t think it was possible to develop Covid vaccines fast enough to be useful. In the summer of 2020, I came to a different conclusion. Now I wanted to look back on how it happened, and suggest boldly that we should ask whether that speed should've been the norm all along.

View full thread
View full thread

It’s common for meta-analyses in the clinical trial literature to lump together studies with different doses, follow-up times, or populations. But often we can do better than that and instead model the dependencies or discrepancies explicitly. One potential payoff is increased statistical precision.

I give a brief introduction to Bayesian model-based network meta-analysis (MBNMA) to model studies on different dose levels of the same drug and show how it can be used to inform an indirect treatment comparison between competitive drugs that have not been studied in the same trial.

Theiss Bendixen reposted

Replying to @theissbendixen.bsky.social

Instead, we cut to the chase and emphasize a practical workflow using step-by-step explanations and real data examples in R. The companion website lives here theissbendixen.com/dag-book and holds: - All data and code used in the book - Free sample chapters - Bonus material!

theissbendixen.comThe Data Analyst's Guide to Cause and EffectThis is the companion website for The Data Analyst's Guide to Cause and Effect

Theiss Bendixen reposted

Replying to @theissbendixen.bsky.social

It took us three years to write this thing. But the good news is you can read it in three days! We cover fairly advanced methods -- counterfactuals, g-computation, inverse probability of treatment weighting, poststratification, missing data imputation, etc. -- without dense formal notation.

Theiss Bendixen reposted

Replying to @theissbendixen.bsky.social

"Strongly application-focused... an effective tool for getting data analysts into the world of causal inference and immediately into a workable project." -- Nick Huntington-Klein, @nickchk.com

View full thread
View full thread

It took us three years to write this thing. But the good news is you can read it in three days! We cover fairly advanced methods -- counterfactuals, g-computation, inverse probability of treatment weighting, poststratification, missing data imputation, etc. -- without dense formal notation.

Nice! Similar phenomenon to assurance (or marginal/average power), where a prior is placed over the effect and power is integrated over it to account for uncertainty, rather than conditioning on a single point estimate. Assurance is also always lower than power in practice.

Dr Mircea Zloteanu 🍂 🍃@mzloteanu.bsky.social

I made a #Shiny app about post hoc power and effect-size uncertainty. If you accept an observed effect, you also need to accept its uncertainty. The app shows how power wobbles when you consider the CI, not just the estimate. Embrace the #wobble #samplesize open.substack.com/pub/mzlotean...

Theiss Bendixen reposted

Imagine a short book (~200 p.) introducing Bayesian statistics in the context of clinical trials and drug development. Scope would be introductory -- sort of "your first short course on Bayes". But practical enough to be applied out of the box. What would you like to see covered in such a text? 👇

Theiss Bendixen reposted

In the Fall I'll be teaching a new MA-level methods course entitled "Applied Statistical Evaluation of Development Projects". It will be 12 weeks, in R, and aimed around RCT evaluations. This is a draft outline. What am I missing? What seems redundant?

Theiss Bendixen reposted

🚨 Blog post: When Using OLS Hurts 😩 I replicated a high-profile study on racial bias in tenure decisions and show the authors weakened their own findings by using OLS instead of ordered beta regression 🤯. Use ordered beta and live your best life 👍 #rstats www.robertkubinec.com/post/ord_bet...

robertkubinec.comWhen Using OLS Hurts – HomepagePeople often use OLS for bounded continuous variables even though we know it isn’t the correct model. Ordered beta regression is a better model–but hard to predict when the results will change. For th...

Imagine a short book (~200 p.) introducing Bayesian statistics in the context of clinical trials and drug development. Scope would be introductory -- sort of "your first short course on Bayes". But practical enough to be applied out of the box. What would you like to see covered in such a text? 👇

View full thread

Imagine a short book (~200 p.) introducing Bayesian statistics in the context of clinical trials and drug development. Scope would be introductory -- sort of "your first short course on Bayes". But practical enough to be applied out of the box. What would you like to see covered in such a text? 👇